Epinephrine Auto-Injector Market Research Report 2022 – Global Forecast to 2027: Increase in the Demand for Self-Management of Anaphylaxis – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Epinephrine Auto-Injector Market Research Report by Dosage, End-User, Region – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Epinephrine Auto-Injector Market size was estimated at USD 292.68 million in 2021, USD 320.33 million in 2022, and is projected to grow at a Compound … [Read more…]

Baxter Highlights Business Strategies and Innovation at 2022 Investor Conference

Company to share strategy for ongoing growth and innovation aligned with mission to save and sustain lives and vision to transform healthcare Recent Hillrom acquisition positions Baxter to accelerate value for patients, clinicians, investors and other stakeholders Company announces strong long-range financial outlook for 2022–2025 DEERFIELD, Ill.–(BUSINESS WIRE)–Baxter International Inc. (NYSE:BAX), a global medtech leader, … [Read more…]

Transcarent Appoints Tim Rosa as Chief Marketing Officer

Former Fitbit Chief Marketing Officer will lead marketing initiatives to support company’s rapid growth while creating a new health and care experience category PALO ALTO, Calif.–(BUSINESS WIRE)–Transcarent, a new, different, and better health and care experience company for employees of self-insured employers and their families, announced today the appointment of Tim Rosa as Chief Marketing … [Read more…]

Anthem Foundation Commits $13 Million to Substance Use Disorder Programs

The Foundation will invest up to $30 million over next three years to programs that support the mental health and well-being of communities with an emphasis on substance use disorders INDIANAPOLIS–(BUSINESS WIRE)–The Anthem Foundation, which will become Elevance Health Foundation on June 28, 2022, today announces the commitment of $13 million in grants to promote … [Read more…]

ATEC to Host Investor Day Today, May 25, 2022

CARLSBAD, Calif.–(BUSINESS WIRE)–Alphatec Holdings Inc. (Nasdaq: ATEC) announced that it will host an Investor Day at the Company’s headquarters in Carlsbad, CA, today. The event, which will highlight ATEC’s commitment to revolutionizing the approach to spine surgery and the Company’s long-term financial outlook, will begin at 8:15 a.m. PT and conclude at approximately 12:00 p.m. … [Read more…]

The Institute of Food Technologists and the Seeding The Future Foundation Announce the Return of the Seeding The Future Global Food System Challenge

The Seeding The Future Global Food System Challenge provides monetary awards in the form of grants and prizes totaling up to one million US dollars annually CHICAGO–(BUSINESS WIRE)–The Institute of Food Technologists (IFT), in collaboration with the Seeding The Future Foundation, is proud to announce the return of the Seeding The Future Global Food System … [Read more…]

iECURE Enters Agreement with Center for Breakthrough Medicines (CBM) to Supply Materials for Future Clinical Programs

Partnership to focus on manufacturing clinical materials for future clinical studies PHILADELPHIA–(BUSINESS WIRE)–iECURE, a gene editing company focused on mutation-agnostic in vivo gene insertion, or knock-in, editing for the treatment of liver disorders with significant unmet need, and Center for Breakthrough Medicines (CBM) today announced the companies have entered into a strategic collaboration wherein CBM … [Read more…]

Terremoto Biosciences Launches With $75 Million Series A Financing and Mission to Discover and Develop Groundbreaking Covalent Medicines

With fundamental advancements made by the founding team, Terremoto’s lysine-based covalency platform holds the potential to expand the covalent drug alphabet and create both best-in-class and first-in-class small molecule medicines Financing co-led by renowned life-science investors OrbiMed and Third Rock Ventures SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Terremoto Biosciences, a biotechnology company leveraging the power of lysine-based … [Read more…]

Endeavor Doses First Patient in Phase 2 Oncology Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib)

Open-Label Trial in Patients with Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations SAN DIEGO–(BUSINESS WIRE)–Endeavor BioMedicines, a clinical-stage biotechnology company targeting the core drivers of terminal diseases including oncology and fibrosis, today announced the first patient has been dosed in an open-label Phase 2 study evaluating ENV-101 (taladegib) in patients with advanced solid … [Read more…]

Imperative Care Announces 10,000 Patients Treated With Its Innovative Stroke Technologies

Company Reaches Milestone During Stroke Awareness Month, Serving as a Reminder to Learn the Signs of Stroke CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc. today announced that 10,000 patients have been treated in the U.S. with its technologies for stroke since 2020. The company’s current portfolio includes the Zoom Stroke Solution™ and TracStar® LDP technologies for ischemic … [Read more…]